"The POSITANO study shows that CAM2029 significantly reduces liver and liver cyst volume compared to placebo while showing improvements in symptoms as assessed by relevant patient ...

The PMS requirement applies to all UKCA- and CE-marked devices, like in vitro diagnostics (IVDs), glucose monitors, and ...

To rein in rising costs, employers can contract directly with a PBM, as well as avoid schemes involving rebates and ...

For a nation that too often has relied on caution as currency, will the G7 presidency offer a new opening for Canada’s ...

The Commission found that the China-based retailer AliExpress failed to mitigate illegal product risks on its platform, as ...

Introduction Over the past few years, the European Union has been actively working to overhaul its pharmaceutical legislative framework to better address unmet medical needs, such as those ...

Early intervention in high-risk smoldering myeloma with lenalidomide delays progression by up to 7 years and achieves ...

Shares in Neuren Pharmaceuticals advanced in morning trade after Macquarie initiated coverage of the biopharmaceutical company with an 'outperform' rating.

Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss ...

The Patented Medicine Prices Review Board (PMPRB) published the 9th edition of its annual Meds Entry Watch report today. Like last year, the analysis ...

Minimizes common user errors by up to 40% and enhances audit readiness by providing end-to-end traceability and data ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.